#cholesterol

Cardiologist Michael Fradley, MD, is the medical director of the Penn Medicine Cardio-Oncology Program at the University of Pennsylvania.

The diabetes medication, alone or in combination regimens, led to improvements in NASH and fibrosis.

Researchers have evidence that cholesterol-lowering drugs might offer a way to improve success rates of immunotherapy.

Researchers found that having a heart attack was associated with a higher risk of developing cancer.

Users can receive checkup reminders for cholesterol tests and mammograms, among other benefits.

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.